Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Crooks

Showing results (191-200 of 319) with videos related to

Pageof 32
Sort By:
Bioorganic & Medicinal Chemistry|September 3, 2013
Synthesis and evaluation of novel azetidine analogs as potent inhibitors of vesicular [3H]dopamine uptakeDerong Ding, Justin R Nickell, Agripina G Deaciuc, et al.
Biomedical Chromatography : BMC|February 17, 2017
Stability studies of potent opioid analgesic, morphine-6-O-sulfate in various buffers and biological matrices by HPLC-DAD analysisJai Shankar K Yadlapalli, Zaineb A F Albayati, Narasimha R Penthala, et al.
Pharmaceutical Research|May 21, 2005
Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexoneHaranath K Vaddi, Mohamed O Hamad, Jianhong Chen, et al.
Journal of Neurochemistry|July 24, 2013
Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivoAndrew C Meyer, Nichole M Neugebauer, Guangrong Zheng, et al.
Life Sciences|December 2, 2017
Preclinical assessment of utility of M6S for multimodal acute and chronic pain treatment in diabetic neuropathyJai Shankar K Yadlapalli, Navdeep Dogra, Anqi W Walbaum, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptorsJoshua T Ayers, Linda P Dwoskin, A Gabriela Deaciuc, et al.
European Journal of Pharmacology|December 18, 2016
GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2Justin R Nickell, Kiran B Siripurapu, David B Horton, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agentsLinda P Dwoskin, Sangeetha P Sumithran, Jun Zhu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2005
In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigsSatyanarayana Valiveti, Dana C Hammell, Kalpana S Paudel, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agentsVijayakumar N Sonar, Y Thirupathi Reddy, Konjeti R Sekhar, et al.
Pageof 32

Showing results (191-200 of 319) with videos related to

Sort By:
Pageof 32
Bioorganic & Medicinal Chemistry|September 3, 2013
Synthesis and evaluation of novel azetidine analogs as potent inhibitors of vesicular [3H]dopamine uptakeDerong Ding, Justin R Nickell, Agripina G Deaciuc, et al.
Biomedical Chromatography : BMC|February 17, 2017
Stability studies of potent opioid analgesic, morphine-6-O-sulfate in various buffers and biological matrices by HPLC-DAD analysisJai Shankar K Yadlapalli, Zaineb A F Albayati, Narasimha R Penthala, et al.
Pharmaceutical Research|May 21, 2005
Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexoneHaranath K Vaddi, Mohamed O Hamad, Jianhong Chen, et al.
Journal of Neurochemistry|July 24, 2013
Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivoAndrew C Meyer, Nichole M Neugebauer, Guangrong Zheng, et al.
Life Sciences|December 2, 2017
Preclinical assessment of utility of M6S for multimodal acute and chronic pain treatment in diabetic neuropathyJai Shankar K Yadlapalli, Navdeep Dogra, Anqi W Walbaum, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptorsJoshua T Ayers, Linda P Dwoskin, A Gabriela Deaciuc, et al.
European Journal of Pharmacology|December 18, 2016
GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2Justin R Nickell, Kiran B Siripurapu, David B Horton, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agentsLinda P Dwoskin, Sangeetha P Sumithran, Jun Zhu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2005
In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigsSatyanarayana Valiveti, Dana C Hammell, Kalpana S Paudel, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agentsVijayakumar N Sonar, Y Thirupathi Reddy, Konjeti R Sekhar, et al.
Pageof 32